Competition radioligand binding assays for the investigation of bispyridinium compound affinities to the human muscarinic acetylcholine receptor subtype 5 (hM(5) ).
about
Drug development for the management of organophosphorus poisoning.Reversed-phase ion-pair chromatography-diode array detection of the bispyridinium compound MB327: plasma analysis of a potential novel antidote for the treatment of organophosphorus poisoning.Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in Mice.Evaluation of the benefit of the bispyridinium compound MB327 for the antidotal treatment of nerve agent-poisoned mice.
P2860
Competition radioligand binding assays for the investigation of bispyridinium compound affinities to the human muscarinic acetylcholine receptor subtype 5 (hM(5) ).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Competition radioligand bindin ...... e receptor subtype 5 (hM(5) ).
@en
Competition radioligand bindin ...... etylcholine receptor subtype 5
@nl
type
label
Competition radioligand bindin ...... e receptor subtype 5 (hM(5) ).
@en
Competition radioligand bindin ...... etylcholine receptor subtype 5
@nl
prefLabel
Competition radioligand bindin ...... e receptor subtype 5 (hM(5) ).
@en
Competition radioligand bindin ...... etylcholine receptor subtype 5
@nl
P2093
P2860
P356
P1476
Competition radioligand bindin ...... e receptor subtype 5 (hM(5) ).
@en
P2093
C M Timperley
H Thiermann
J E H Tattersall
K V Niessen
P2860
P304
P356
10.1002/DTA.410
P50
P577
2012-02-24T00:00:00Z